261 filings
Page 2 of 14
8-K
2w8ng m7d
8 Jan 24
Departure of Directors or Certain Officers
6:45am
DEFA14A
gl52xt0ep2kj4oo 8r
19 Dec 23
Additional proxy soliciting materials
8:32am
SC TO-C
vemuljuhqxtubg
8 Dec 23
Information about tender offer
9:00am
PRE 14A
sb0gmkyk7
8 Dec 23
Preliminary proxy
8:30am
8-K
7e13e j37w
7 Nov 23
Entry into a Material Definitive Agreement
7:39am
424B5
8mspqce4ti opl
7 Nov 23
Prospectus supplement for primary offering
7:29am
8-K
tmj33 4hbht4
7 Nov 23
Sage Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
6:46am
8-K
nem6i6c2e7e5ct jgwy
31 Aug 23
Cost Associated with Exit or Disposal Activities
6:45am
S-8
68bz2q8 a1y5eksaed
7 Aug 23
Registration of securities for employees
7:49am
8-K
o5h7avy2yht17 gx
7 Aug 23
Sage Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
6:45am
8-K
ny3xovk
16 Jun 23
Departure of Directors or Certain Officers
4:06pm
DEFA14A
b2dnr
7 Jun 23
Additional proxy soliciting materials
4:05pm
8-K
ijzc5
2 May 23
Sage Therapeutics Announces First Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
6:45am
ARS
45j1g4f j7a
27 Apr 23
Annual report to shareholders
4:11pm
DEFA14A
o9f03qpoqu0
27 Apr 23
Additional proxy soliciting materials
4:08pm